nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review
|
Hirte, Hal |
|
|
162 |
C |
p. |
artikel |
2 |
Critical review of oncology clinical trial design under non-proportional hazards
|
Ananthakrishnan, Revathi |
|
|
162 |
C |
p. |
artikel |
3 |
Cross-talk between next generation sequencing methodologies to identify genomic signatures of esophageal cancer
|
Verma, Renu |
|
|
162 |
C |
p. |
artikel |
4 |
Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications
|
De Nola, Rosalba |
|
|
162 |
C |
p. |
artikel |
5 |
Editorial Board
|
|
|
|
162 |
C |
p. |
artikel |
6 |
Effectiveness of photobiomodulation therapy in radiation dermatitis: A systematic review and meta-analysis
|
Aguiar, Beatriz Regina Lima de |
|
|
162 |
C |
p. |
artikel |
7 |
Impact of tumor site on the prognosis of salivary gland neoplasms: A systematic review and meta-analysis
|
dos Santos, Erison Santana |
|
|
162 |
C |
p. |
artikel |
8 |
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm
|
Marotta, Vincenzo |
|
|
162 |
C |
p. |
artikel |
9 |
Late radiation effects in survivors of head and neck cancer: State of the science
|
Ortigara, Gabriela Barbieri |
|
|
162 |
C |
p. |
artikel |
10 |
Letter to the Editor regarding the article “Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis”
|
Yang, Tingfang |
|
|
162 |
C |
p. |
artikel |
11 |
Managing side effects of immune checkpoint inhibitors in breast cancer
|
Criscitiello, Carmen |
|
|
162 |
C |
p. |
artikel |
12 |
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer
|
Berti, Alvise |
|
|
162 |
C |
p. |
artikel |
13 |
Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review
|
Hirte, Hal |
|
|
162 |
C |
p. |
artikel |
14 |
Osteosarcoma, chondrosarcoma and Ewing sarcoma: Clinical aspects, biomarker discovery and liquid biopsy
|
Aran, Veronica |
|
|
162 |
C |
p. |
artikel |
15 |
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance
|
Vitale, Silvia Rita |
|
|
162 |
C |
p. |
artikel |
16 |
Risk Factors of Fluoropyrimidine Induced Cardiotoxicity among Cancer Patients: A Systematic Review and Meta-analysis
|
Li, Chao |
|
|
162 |
C |
p. |
artikel |
17 |
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
|
De Felice, Francesca |
|
|
162 |
C |
p. |
artikel |
18 |
The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions
|
Caruso, Giuseppe |
|
|
162 |
C |
p. |
artikel |
19 |
Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?
|
Mir, Tajamul H. |
|
|
162 |
C |
p. |
artikel |
20 |
Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients
|
Devarajan, Nalini |
|
|
162 |
C |
p. |
artikel |